Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.
Timeline
Funded Companies
Evolve Biosystems is a company developing a consumer product, Evivo, that improves infants' gut health.
Aquapharm Biodiscovery is a company in the pharmaceuticals industry.
People
Heather Roxborough
Principal
David Atkinson
Managing Partner
Simon Barnes
Managing Partner
Further reading
Documentaries, videos and podcasts
Companies
Allylix
Aquapharm Biodiscovery
Changing Health
Evolve Biosystems
Lumora
Nutriati
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Melanie Manipula
Helping organize knowledge. - 3
Reys Phillips
A graduate of Cleveland State University with a Bachelor of Science in Education. My main hobbies include story writing and reading. - 4
Aime Anne Nisay
QA Engineer of web and mobile applications